SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014036
Filing Date
2021-04-23
Accepted
2021-04-23 08:30:54
Documents
6
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10022460x1_def14a.htm DEF 14A 601996
2 logo_pmvpharma.jpg GRAPHIC 55635
3 nc10022460x1_pc01.jpg GRAPHIC 483173
4 nc10022460x1_pc02.jpg GRAPHIC 350008
5 sig_davidhmack.jpg GRAPHIC 15618
6 sig_robertticktin.jpg GRAPHIC 17857
  Complete submission text file 0001140361-21-014036.txt   1872017
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39539 | Film No.: 21846779
SIC: 2834 Pharmaceutical Preparations